Rupatadine oral solution for 2–5-year-old children with allergic rhinitis: a safety, open-label, prospective study

BACKGROUND: There are few clinical trials that assess the efficacy of antihistamines in very young children. Rupatadine is a second-generation antihistamine indicated for the treatment of allergic rhinitis (AR) and urticaria. In this study, AR symptoms were evaluated before and after daily 1 mg/mL r...

Descripción completa

Detalles Bibliográficos
Autores principales: Santamaría, Eva, Izquierdo, Iñaki, Valle, Marta, Vermeulen, Jan, Potter, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128281/
https://www.ncbi.nlm.nih.gov/pubmed/30214250
http://dx.doi.org/10.2147/JAA.S164632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128281/
https://www.ncbi.nlm.nih.gov/pubmed/30214250
http://dx.doi.org/10.2147/JAA.S164632

Ejemplares similares